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Background. Vibrio cholerae excreted by cholera patients is ‘‘hyperinfectious’’ (HI), which can be modeled by
passage through infant mice. Immunization of adult female mice with V. cholerae outer-membrane vesicles (OMVs)
passively protects suckling mice from challenge. Although V. cholerae is unable to colonize protected pups, the
bacteria survive passage and have the potential to be transmitted to susceptible individuals. Here, we investigated the
impact of OMV immunization and the HI state on V. cholerae transmission.
Methods. Neonatal mice suckled by OMV- or sham-immunized dams were challenged with HI V. cholerae. The
infectivity of spatially and temporally separate V. cholerae populations obtained from infected naive or protected
pups was tested. Recombination-based in vivo expression technology was used to assess virulence gene expression
within these populations.
Results. OMV immunization significantly reduced colonization of neonates challenged with HI V. cholerae.
Vibrio cholerae that had colonized the naive host was HI, whereas V. cholerae excreted by neonates born to
OMV-immunized dams, although viable, was hypoinfectious and failed to fully induce virulence gene expression.
Conclusions. OMV immunization can significantly reduce the V. cholerae burden upon challenge with HI
V. cholerae and can also block transmission from immune mice by reducing the infectivity of shed bacteria.
Vibrio cholerae is the causative agent of cholera and
a natural inhabitant of aquatic environments [1, 2].
Pathogenic V. cholerae evolved to multiply in the human
small intestine (SI), in part by acquiring genes encoding
cholera toxin and the toxin-coregulated pilus [3]. In-
duction of these genes occurs in the infant mouse
model of colonization and is required for pathogenesis
in humans [4–6].
Vibrio cholerae excreted in stool are transiently hy-
perinfectious (HI) [7, 8], which is proposed to help
explain the rapid spread of cholera [9]. This state can be
modeled by passage through suckling mice [10]. One
factor correlated with the HI state is an alteration in
chemotaxis [7, 8] that enables V. cholerae to colonize
proximal regions of the SI [10, 11].
Outer-membrane vesicles (OMVs) are naturally
produced by V. cholerae and, when delivered to adult
female mice intranasally or orally, can protect their
suckling neonates from challenge with in vitro grown,
non-HI V. cholerae [12, 13]. The lipopolysaccharide
O-antigen is the major protective OMV antigen, and
inhibition of V. cholerae motility may contribute to
protection [14]. V. cholerae is unable to colonize the SI
of protected pups but passes out of the host without
being killed [14].
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Because natural infection may occur predominantly by ex-
posure to HI stool-shed V. cholerae, we investigated the ability of
the OMV vaccine to block infection by HI V. cholerae and the
ability of V. cholerae from challenged immune and nonimmune
neonatal mice to participate in disease transmission.
MATERIALS AND METHODS
Bacteriology
The V. cholerae strains that we used are described in the Sup-
plementary methods below. Bacteria were cultured in Luria-
Bertani (LB) broth with aeration or on LB agar at 37C (unless
otherwise stated), supplemented with 100 lg/mL streptomy-
cin (Sm), 50 lg/mL rifampicin (Rif), 30 lg/mL ampicillin (Ap),
or 3 lg/mL tetracycline (Tc). Competitions using blue/white
screening were LB agar supplemented with 80 lg/mL 5-bromo-
4-chloro-3-indolyl-D-galactoside (X-gal).
Mice
BALB/c mice (Charles River Laboratories) were used in experi-
ments in Boston, and Swiss Webster mice were used in Dhaka.
Mice were housed with food and water ad libitum and monitored
in accordance with the rules of the Department of Laboratory
Animal Medicine at Tufts Medical Center or the International
Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B).
Immunization
OMVs from V. cholerae strains E7946 and A1552 were prepared
as described [12]. Immunization was carried out with 3 doses
(days 0, 14, and 28) of 25 lg of OMV, and mice were mated
41 days postimmunization [12]. For immunization of mice in
Dhaka, a 1:1 mixture of Ogawa and Inaba OMVs was used; in
Boston, Ogawa OMVs were used.
For Swiss Webster mice in Dhaka, overall pregnancy rates
were only approximately 45%. Mice that had not given birth
were rebred and rice-water-stool challenges were carried out at
143–149 days and final bleeds were carried out at 153 days
postimmunization.
Measuring Anti-OMV Antibodies
Enzyme-linked immunosorbent assays (ELISAs) against OMVs
were carried out as described [12, 14]. Because BALB/c mice
mount an immunoglobulin (Ig) G1–dominant response [12],
this isotype is reported. Responses of Swiss Webster mice to
OMV immunization had not previously been tested; therefore,
IgG1, IgG2, IgA, and IgM were monitored.
Mouse-passaged V. cholerae Challenge and Median Infective
Dose
Naive 5- to 6-day-old pups were infected with approximately
105 colony-forming units (CFU) of E7946 in 50 lL by intra-
gastric inoculation and returned to their dams as described [12].
After 24 hours mice were euthanized and SIs were homogenized
in 1 mL of saline, pooled (from 2 or 3 mice), filtered (100-lm
pores), and diluted 10-, 100-, and 1000-fold. Neonates from
BALB/c mice, OMV- or sham-immunized, were challenged
intranasally with 50 lL of primary infection homogenate.
Twenty-four hours after inoculation, mice were euthanized and
SIs were homogenized. Inputs and outputs were diluted and
plated for determination of viable counts.
The ID50 (the doses at which half of the animals are infected)
of mouse-passaged V. cholerae E7946 from 24-hour SI homoge-
nates and from 2-hour large intestinal (LI) homogenates, post-
inoculation of pups born to sham- or OMV-immunized dams
were determined by primary and secondary infection as de-
scribed above, with primary inputs of 105 CFU for 24-hour or
107 CFU for 2-hour infections. Groups of 4–7 mice were in-
fected with serial dilutions of homogenates in saline. The
proportion of mice infected, with cutoff set to .100 CFU/SI,
was plotted against input dose. The ID50 required to colonize
half of the mice was calculated using Hill regression.
Challenge With Rice-Water-Stool V. cholerae
Stool samples were collected from cholera patients aged
$15 years. Use of these samples was approved by the in-
stitutional review boards at both Massachusetts General Hospital
and the ICDDR,B. Dark field–positive, serologically confirmed
stool samples containing 1.7–1300 3 106 CFU/mL V. cholerae
were utilized for infections. Stool was clarified by 5 minutes’
centrifugation at 380g. The supernatant was diluted 1000-fold
(high dose) and 10 000-fold (low dose) in LB. Oral challenge of
Swiss Webster neonates was then carried out as described
above. Half of each litter was infected with low dose and half
with high dose. Twenty-four hours postinoculation, the neonates
were euthanized, and SIs were harvested and homogenized in
1 mL LB 15% glycerol. Stomachs were also extracted and frozen
for future analysis of stomach contents (milk). Infection inputs
and SI outputs were diluted and plated on taurocholate-tellurite-
gelatin agar and MacConkey agar plates for enumeration of
V. cholerae and Escherichia coli contamination, respectively.
Two samples that contained .2% E. coli CFU were excluded.
All isolates of E. coli tested were polymerase chain reaction–
negative for heat-labile or heat-stable toxins (data not shown),
suggesting that V. cholerae, rather than enterotoxigenic E. coli,
was the cause of the patients’ rice-water stool.
Competition Experiments
Competition experiments were carried out using wild-type and
lacZ mutant V. cholerae. Primary infections with in vitro–grown
(from LB agar) V. cholerae were carried out with either lacZ-
positive or negative bacteria as described above, with input doses
of 105 or 107 CFU for 24-hour and 2-hour infections, respectively.
Neonates were euthanized and the whole intestine, SI or LI, was
extracted and homogenized in 1 mL of saline. Homogenates
diluted 10-fold and/or in vitro–grown bacteria were mixed 1:1
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and used for secondary naive neonatal mouse infections with
an input dose of approximately 5 3 104 CFU/50 lL. Twenty-
four hours after secondary infection, the neonates were euthanized
and SIs were homogenized in 1 mL LB 15% glycerol. Dilutions of
both inocula and infection outputs were plated on X-gal plates
for enumeration of lacZ-positive (blue) and lacZ-negative (white)
colonies.
Induction of tcpA In Vivo
Infections were carried out with AC585, which is a derivative of
the SmR V. cholerae strain E7946, having a TcR gene flanked by
resolvase recognition sequences inserted into the native lacZ
gene, and tnpR resolvase under control of the native tcpA pro-
moter via integration of an ApR suicide vector into the tcpA locus.
Bacteria were prepared from LB SmApTet agar and diluted in
LB to give either 105 CFU (24-hour infection of naive mice)
or 107 CFU (2-hour or 24-hour infection of immune mice) in
50 lL. In parallel, the bacteria were diluted 1000-fold into
10 mL of LB or in the tcpA-inducing medium known as ‘‘AKI’’
(0.5% sodium chloride, 0.3% sodium bicarbonate, 0.4% yeast
extract, 1.5% Bacto-Peptone) [15]. Cultures were grown
shaking (LB) or statically (AKI) for 4 hours, then 1 mL was
removed and grown shaking for 4 hours. Twenty-four hours
postinoculation, the mice were euthanized and SI or LI were
homogenized separately. Homogenates and 8-hour in vitro
cultures were diluted and plated on LB SmAp. The resulting
colonies were replica plated onto LB SmAp and LB SmApTc
to determine the percentage of resolved (TcS) CFUs.
Visualization of V. cholerae In Vivo
Intestinal homogenates were fixed with 3.7% formaldehyde for
30 minutes, vortexed, and mixed with a pipette; 10-lL samples
were then spotted on poly-L-lysine slides (Polysciences Inc),
dried at 37C, dipped into ethanol, and washed in phosphate-
buffered saline (PBS). Samples were blocked with PBS 5% goat
serum 1% bovine serum albumin for 1 hour, then stained for
1 hour with fluorescein isothiocyanate (FITC)–conjugated
mouse IgG1 anti–V. cholerae O1 antibody (250-fold dilution;
New Horizons), DNA stain (2 lg/mL; Hoescht-33342, Mo-
lecular Probes), and a lectin that highlights mucus (2 lg/mL
tetramethylrhodamine-5-(and 6)-isothiocyanate–wheat germ ag-
glutinin, Sigma Aldrich). Negative control FITC-mouse IgG1 was
used to stain consecutive sections (data not shown).
Statistics
The majority of data were abnormally distributed; therefore,
2 groups were compared using Mann–Whitney U tests and .2
groups were compared using the Kruskal–Wallis and Dunn
tests. Normally distributed data were analyzed using 1-sample
t test or 1-way analysis of variance and post hoc t tests with
Bonferroni adjustment. For ratios and percentages, data were
log10-transformed prior to analysis. GraphPad Prism soft-
ware, version 5.0a, was used for all statistical analysis.
RESULTS
OMV Immunization Protects Against Mouse-Passaged
Hyperinfectious Challenge
To test whether OMV immunization, which protects from in
vitro–grown V. cholerae challenge [12–14], can also protect from
host-passaged HI V. cholerae challenge, we first determined the
ID50 for the latter in suckling BALB/c mice. The ID50 for strain
E7946 was 4.1 CFU (95% confidence interval [CI], 2.2–6.0;
R2 5 0.98; Figure 1A), which is 50 times lower than LB-grown
E7946 [12]. We considered that clumping could cause input
doses to be underestimated. We scored clumps of V. cholerae in
formaldehyde-fixed homogenates prepared as if for infection
and found very few in 24-hour postinoculation SI homogenates
(Figure 2A and 2B), suggesting that a genuine change in bacterial
physiology upon host passage accounts for the low ID50.
Pups from OMV- and sham-immunized mice were challenged
with mouse-passaged E7946 from infected SI homogenates
(median inputs in Figure 1B). Pups born to OMV-immunized
mice were significantly protected from colonization by HI mouse-
passaged V. cholerae, even at the highest input dose (Figure 1B).
OMV Immunization Protects Against Rice-Water-Stool
V. cholerae Challenge
Mouse-passaged V. cholerae competes 1:1 with rice-water-stool
V. cholerae in the mouse infection model [10]. However, it is not
clear whether mouse passage elicits the same HI phenotype as
human passage. To test whether pups from immunized mice are
protected from human-passaged HI V. cholerae, we performed
challenge studies with rice-water stool at the ICDDR,B using
Swiss Webster mice. We first characterized the immune re-
sponse of Swiss Webster mice after OMV immunization. Anti-
OMV antibody titers in unimmunized control mice remained
below the limit of detection, except for a slight increase above
baseline for IgG2a and IgA over time (Figure 3). Anti-OMV
IgG1, IgG2a, and IgA titers were above control levels for in-
tranasally OMV-immunized mice 38–95 days (153 for IgG1)
postimmunization (Figure 3A) but were lower than those
seen with BALB/c mice [12, 14]. Oral immunization induced
less robust immune responses than intranasal immunization
(Figure 3A), as previously observed [14]. A delayed increase in
anti-OMV IgG1, IgG2a, and IgA in the orally OMV-immunized
group, reaching levels higher than those of the controls at days
95–153 (Figure 3A), could be due to environmental contami-
nation boosting the response; a small rise in anti-OMV IgG2a
and IgA was observed in unimmunized controls over time
(Figure 3A). Anti-OMV IgM was detectable in OMV-immunized
mouse serum but was at similar levels in preimmune and control
sera (Figure 3A) and thus probably represents innate anti-
carbohydrate antibodies [16]. Similar ELISA results were seen
with O1 Inaba (data not shown) and O1 Ogawa (Figure 3) OMVs
as the ELISA substrate.
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To determine if pups from OMV-immunized mice are pro-
tected from challenge with rice-water-stool V. cholerae, stools
were collected from patients in the ICDDR,B. During this period
(April–May 2009), all V. cholerae–positive stool samples ana-
lyzed contained O1 serotype Ogawa. Two dilutions of rice-water
stool were used for infections. Despite relatively low antibody
responses in the dams (Figure 3), their pups showed significantly
lower intestinal burdens than cohoused unimmunized controls
challenged 62–76 days postimmunization (Figure 4A). In the
second challenge experiment, 143–149 days postimmunization,
protection did not reach statistical significance for the oral
group with low input dose due to poor colonization of controls,
but intestinal burdens were significantly reduced in all other
immunization groups (Figure 4B). These data indicate that
OMV immunization of dams provides passive protection to pups
challenged with naturally transmitted rice-water-stool V. cholerae.
Suckling from an immunized dam provides the majority of
neonatal protection [13]. IgG1, IgG2a, and IgA, but not IgM,
responses were detectable in OMV-immunized mouse milk
samples and were significantly higher than those of controls after
intranasal immunization (Figure 3B).
V. cholerae Excreted by Challenged Protected Mice Is
Hypoinfectious
We previously observed that challenged pups suckled by OMV-
immunized dams contain live V. cholerae in the LI 2–4 hours
postinoculation, similar to challenged pups born to sham-
immunized mice [14]. We were interested in determining
whether bacteria excreted by protected neonates were infectious.
First, we determined that 107 CFU challenge of pups from
immune mice provides enough V. cholerae in the LI 2 hours
postinoculation to be used for reinfection (data not shown).
Again, we were concerned that clumping could confound our
interpretation of input doses. More clumps (Figure 2B), but
similar viable counts (Figure 2B), were seen in 2-hour post-
inoculation homogenates from challenged pups born to OMV-
immunized rather than to sham-immunized mice. This suggests
that upon challenge of secondary mice with the former in-
oculum, we are introducing more clumped bacteria than with
the latter. However, the clumps appeared to be debris to which
multiple individual bacteria were sparsely attached, rather than
bacteria intimately associated with each other (Figure 2A). We
also confirmed, by staining of V. cholerae in infected intestinal
samples and scoring of bacterial localization, that bacteria in
the LI are in transit within the lumen as opposed to colonizing
(Supplementary Figure 1).
With these controls in place, we carried out competition ex-
periments with differentially marked, equally virulent (lacZ plus
or minus) strains of V. cholerae to determine the infectivity of
different host-passaged bacterial populations, as depicted in
Figure 5A. First, we compared infected whole-intestine, SI, and
LI homogenates harvested 24 hours postinoculation in compe-
tition with in vitro LB-grown V. cholerae. Regardless of whether
the bacteria were exiting the host via the LI or were in the SI, they
were all HI (Figure 5B, competitions 1–3). Competition between
SI and LI homogenates 24 hours postinoculation confirmed that
they compete approximately 1:1 (Figure 5B, competition 4). LI
homogenates 2 hours postinoculation contain V. cholerae that
failed to colonize the SI and were in transit out of the host. This
Figure 1. Challenge of outer-membrane vesicle (OMV)–immunized mice
with hyperinfectious, mouse-passaged Vibrio cholerae. A, ID50 (the dose
at which half the animals are infected) for secondary infection using, as
inoculae, mouse-passaged V. cholerae E7946 recovered from primary
infection small intestinal (SI) homogenates. Infected BALB/c neonates
were returned to their dams postinoculation. Primary infection was with
105 E7946 from Luria-Bertani agar plates. Secondary infection was with
SI homogenates diluted in saline to between 0.1 and 3 3 104 colony-
forming units (CFU)/50 lL challenge dose. Secondary infections were
done in groups of 4–10 mice per challenge dose. Both primary and
secondary infections were for 24 hours. The proportion of mice infected,
with a colonization cutoff of .100 CFU, versus challenge dose is
shown, from which the ID50 was calculated to be 4.1 (95% confidence
interval, 2.200–5.995; R 2 5 0.9814). B, Challenge of neonates born to
sham- (control) or OMV-immunized dams with mouse-passaged V. cholerae
was carried out with 3 challenge doses (median challenge doses
indicated below the graph). Each symbol represents 1 neonate. Neonates
from 3 mice are represented in each group. Bars 5 medians; dotted
line 5 limit of detection. *P , .05 comparing pups born to controls and
immunized mice infected with the same challenge dose (Mann–Whitney
U tests). The anti-OMV enzyme-linked immunosorbent assay immuno-
globulin G1 titers for immunized dams whose pups were used for this
experiment ranged from 10.5 to 159 (median, 143) lg/mL.
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population from naive mice only slightly, but significantly,
outcompeted LB-grown bacteria (Figure 5B, competition 5).
Competition of 2-hour LI homogenates with 24-hour LI ho-
mogenates showed an in-between phenotype (Figure 5B,
competition 6). These data together show that passive passage
of V. cholerae through the host (2-hour LI) provides a small
advantage over in vitro–grown bacteria, but this advantage is an
order of magnitude less than bacteria that have colonized the SI
24 hours postinfection.
To shed light on whether the OMV vaccine has the potential
to reduce transmission, we competed 2-hour LI homogenates
from OMV-immunized mice with in vitro–grown or 2-hour
passively passaged (without colonization) bacteria. The bacteria
from immune pups were severely outcompeted in each case
(Figure 5B, competitions 7 and 8), indicating that the former
bacteria are hypoinfectious. Vibrio cholerae that started off HI,
then passed through an immune host, were also unable to com-
pete against LB-grown V. cholerae (Figure 5B, competition 9) or
V. cholerae exiting naive mice 2 hours after challenge with HI
bacteria (Figure 5B, competition 10).
We also determined the ID50 of LB-grown V. cholerae that had
passed transiently (2 hours) through naive or immune hosts.
The ID50 for bacteria passively transiting through the LI of naive
hosts was 27.3 CFU (95% CI, 1–57; R2 5 0.97; Figure 5C). This
Figure 2. Clumping of Vibrio cholerae within infected intestinal homogenates. Clumping of V. cholerae within infected mouse intestinal homogenates
was assessed by visualization of formalin-fixed samples stained with fluorescein isothiocyanate–mouse anti-O1 V. cholerae antibody. A, Representative
images of clumps within homogenates from small intestine (SI) (i ) or large intestine (LI) (ii–iv ) harvested 24 hours (i, ii ) or 2 hours (iii, iv ) postinoculation
and stained for V. cholerae. Scale bars 5 20 lm. B, (i ) Clumps of V. cholerae were scored in at least 20 fields of view with a 360 objective from
2 samples taken from 5 fixed SI or LI homogenate samples that were harvested 2 hours or 24 hours postinoculation, as indicated. The number of clumps
per field of view is shown. *P, .05 (1-way analysis of variance and post hoc t tests with Bonferroni adjustment). (ii ) Viable counts (colony-forming units
[CFU]/mL) for each homogenate, prepared as if for mouse infection, determined by serial dilution and plating prior to formaldehyde fixing. Each symbol
represents 1 homogenate; bars 5 means. Abbreviation: OMV, outer membrane vesicle.
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Figure 3. Immune responses of outer-membrane vesicle (OMV)–immunized Swiss Webster mice. Adult female Swiss Webster mice were immunized
with three 25-lg doses of a 1:1 mixture of O1 Ogawa and O1 Inaba OMVs either intranasally (nasal, 10 mice) or by oral gavage (oral, 9 mice) at days 0, 14,
and 28. Controls (19 mice) were cohoused with the immunized mice. Enzyme-linked immunosorbent assays (ELISAs) for serum and milk samples from
these mice were carried out against O1 Ogawa OMVs. A, Serum levels of anti-O1 Ogawa OMV immunoglobulin (Ig) G1 lg/mL (i ), IgG2a lg/mL (ii ),
IgA lg/mL (iii ), and IgM lg/mL (iv ) assessed by ELISA for preimmune serum (day 0) and serum samples taken at various days postimmunization, as
indicated on the x-axis of each graph: day 37, before mating; day 95, after initial neonatal rice-water-stool challenges; day 153, after second round of
challenge experiments. Sera from at least 6 mice per group were analyzed at each time point, except for day 153 when only 4 mice remained in the orally
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is 7-fold higher than 24-hour SI homogenates (Figure 1A) and
10-fold lower than LB-grown bacteria (ID50 5 200 CFU [12]).
In contrast, V. cholerae from immune hosts were slightly reduced
in their capacity to colonize a new host compared with LB-grown
bacteria, with an ID50 of 454. However, there was a great deal of
variability in the data (95% CI, 1–2411; R2 5 0.91; Figure 5C).
Virulence Gene Induction Is Blocked in Immune Mice and
During Passive Transit in Naive Mice
Upon host entry, V. cholerae induces virulence genes including
tcpA encoding the pilin subunit for the toxin-coregulated pilus.
We monitored tcpA induction using a strain with a resolvase
transcriptional fusion to tcpA and a resolvable cassette encoding
TcR, as described previously [6]. For El Tor biotype V. cholerae,
the tcpA operon can be induced in vitro in AKI broth [15]. As
a control we showed that AKI results in 60% resolution of the
reporter strain (Figure 6A). Infection of mice with 105 V. cholerae
induced the fusion, resulting in complete resolution after
24 hours in the SI (Figure 6B). Using a high (107) input dose,
1000–100 000 V. cholerae overcame inhibition of colonization
in immune mice and managed to reside in the host for 24 hours
(Figure 6D). V. cholerae populations in both the SI and LI,
however, showed significantly less tcpA induction than those
that had colonized an unimmunized host (Figure 6B). This
suggests that the niche in which the bacteria managed to reside
in an immune host is not conducive to tcpA activation.
Transient passage through a host for 2 hours induced tcpA to
a low level, which was significantly higher in the SI (where
colonization occurs) than in the LI, regardless of whether the
host was suckling from an OMV- or sham-immunized dam
(Figure 6C). This suggests that signals for tcpA induction are
more active for bacteria in the early stages of SI colonization
than for V. cholerae being excreted through the LI without
colonization. However, full induction does not occur in either
environment early after infection.
DISCUSSION
The physiological state of stool-borne, HI V. cholerae is different
from that of laboratory-grown bacteria [7, 8, 17]. Here we show
that OMV immunization of mouse dams provides significant
protection to their suckling pups challenged with HI V. cholerae,
using both infant mouse-passaged and human rice-water-stool
HI V. cholerae. This was true for inbred mice mounting a strong
antibody response (BALB/c) and for outbred mice (Swiss
Webster) mounting a less robust response. Thus, OMV im-
munization can significantly reduce the intestinal burden
upon challenge with HI V. cholerae, as would occur during
a cholera outbreak.
The question of whether immunity to cholera after natural
infection or immunization leads to killing of bacteria or just
prevents their colonization, but without sterilizing immunity, is
important with respect to blocking of cholera transmission by
infection- or vaccination-mediated immunity. In the suckling
mouse passive-protection model with OMV immunization, al-
though anti-V. cholerae antibodies prevent V. cholerae from
colonizing the SI, and vibriocial antibodies are present in serum
from immunized mice, the bacteria are not killed (by viable
Figure 3 continued. immunized group. Symbols 5 medians; error bars 5 interquartile range. *P , .05 compared with controls at the same time point
(Kruskal–Wallis and Dunn tests). B, Levels of anti-O1 Ogawa OMV IgG1 lg/mL (i ), IgG2a lg/mL (ii ), IgA lg/mL (iii ), and IgM lg/mL (iv ) in milk extracted
from the stomachs of pups born to OMV-immunized (nasally or orally delivered as indicated) or control mice. Each symbol represents milk pooled from the
stomachs of at least 3 pups suckled by 1 dam; bars 5 medians. *P , .05 compared with controls (Kruskal–Wallis and Dunn tests).
Figure 4. Challenge of outer-membrane vesicle (OMV)–immunized Swiss
Webster mice with rice-water-stool Vibrio cholerae. Neonates born to
intranasally or orally O1 OMV-immunized or cohoused (control) dams were
challenged with cholera patient rice-water-stool samples diluted to give the
median challenge doses indicated. Challenges were carried out either
(A ) 62–76 days or (B ) 143–149 days postimmunization of the dam. Each
symbol represents viable counts in the small intestine of 1 challenged
neonate; bars 5 medians. *P , .05 significantly lower viable counts
compared with controls with the same challenge dose (Kruskal–Wallis and
Dunn tests). Abbreviation: CFU, colony-forming units.
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counts 1 hour postinfection) and can be followed into the colon
2–4 hours postinfection [14]. Using competitions and ID50 assays,
we show that V. cholerae that has passed through an immune host
is compromised in its ability to colonize a new host. We hypo-
thesize that V. cholerae is bound by antibodies that reduce its
ability to infect new hosts through a reduction of motility and/or
clumping. Thus, in the mouse passive-protection model, OMV
immunization inhibits both primary infection and transmission
to secondary hosts despite a lack of sterilizing immunity.
In humans, the extent of killing of V. cholerae in immune
individuals varies. A human volunteer challenge study showed
that after rechallenge following primary infection, only 1 of 16
volunteers excreted culturable V. cholerae [18], suggesting that
after natural infection, adult immunity is sterilizing. However,
when volunteers immunized with oral live-attenuated or whole-
cell killed cholera vaccines were challenged with V. cholerae,
shedding of the challenge strain was observed in the majority
of individuals who were protected from symptomatic cholera
[19–21]. Therefore, it may be that bacterial killing is more ef-
fectively induced by natural infection than by immunization.
Our data in mice suggest that upon exiting an immunized host,
stool-shed V. cholerae are hypoinfectious, making them less
likely to be transmitted. This may be a contributing factor to the
herd immunity reported following immunization with the
whole-cell killed oral vaccine Dukoral [22, 23].
Figure 5. Infectivity of neonatal mouse host-passaged Vibrio cholerae
2 hours or 24 hours postinoculation and the impact of outer-membrane
vesicle (OMV) immunization. A, Scheme for competitions between
V. cholerae passaged through immunized (OMV) or unimmunized mice for
2 hours or 24 hours, or V. cholerae E7946 grown on Luria-Bertani (LB)
plates. Secondary infection of naive mice was with mixes of mouse-
passaged whole intestine (WI), small intestine (SI), or large intestine (LI)
homogenates or LB-grown (LB) bacteria mixed 1:1. After 24 h, SIs were
harvested from secondary infections and plated for viable counts. Strains
were differentially marked by the presence or absence of lacZ, allowing
them to be differentiated in competition outputs by the ratio of blue to
white bacteria on 5-bromo-4-chloro-3-indolyl-D-galactoside (X-gal) plates.
B, Competition index5 ratio of SI output/ratio of input. Input ratios were
,10:1 and .0.1:1 unless otherwise stated. Competitions were carried
out between (1) 24 h WI homogenate V. cholerae (24 h WI) vs LB-grown
V. cholerae E7946 (LB); (2) 24 h SI homogenate (24 h SI) vs LB; (3) 24 h LI
homogenate (24 h LI) vs LB; (4) 24 h SI vs 24 h LI; (5) 2 h LI homogenate
(2 h LI) vs LB; (6) 24 h LI vs 2 h LI; (7) 2 h LI homogenate from neonates
Figure 5 continued. born to OMV-immunized dams (OMV 2 h LI) vs LB;
(8) OMV 2 h LI vs 2 h LI. Where primary infections were carried out with
mouse-passaged hyperinfectious (HI) 24-h SI homogenate, rather than
with LB-grown V. cholerae, is indicated by (HI). Competitions were carried
out between (9) OMV 2 h LI (HI) vs LB; (10) OMV 2 h LI (HI) vs 2 h LI (HI).
Each symbol represents the competitive index from 1 SI homogenate from
a naivemouse infectedwith the indicated competitionmix; bars5 geometric
means (GeoMean). *P , .05 significantly different from 1 (single sample
t tests). In each case, a lacZ mutant and lacZ wild-type swap was
performed. The pooled data from at least 2 experiments, including the
lacZ swap, with at least 6 neonates per group are shown. A 1:1 input
ratio LB vs LB control competition had a GeoMean competitive index of
1.75 (data not shown). a Competition 9 input ratios were 1:32 and 1:45;
to clarify the impact of this deviation from a 1:1 input ratio, an
additional control LB vs LB competition was carried out, with inputs of
1:26 and 1:33, which resulted in a GeoMean competitive index of 0.18
(data not shown); thus, for competition 9 the GeoMean competitive
index of 0.001148 cannot be attributed only to the lack of a 1:1 input ratio.
b Outlier identified and excluded with the Grubb test (P, .01). Where OMV-
immunized mice were infected (competitions 7–10), the anti-O1 Ogawa
OMV immunoglobulin (Ig) G1 titers by enzyme-linked immunosorbent
assay (ELISA) (terminal bleeds) ranged from 23.4 to 112.8 (median,
36.7) lg/mL. C, ID50 (the dose at which half of animals are infected) for
2-hour postinoculation LI homogenates from neonates born to unimmunized
(2-h LI) or intranasally OMV-immunized (OMV 2-h LI) mice used to infect
naive neonates with doses from 1 to 105 colony-forming units (CFU). The
anti-O1 Ogawa OMV ELISA IgG1 titers (terminal bleeds) for 4 immunized
dams whose pups were used for the ID50 experiment ranged from 18.6 to
114 (median, 73.2) lg/mL.
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In making observations about transmission in mouse models,
we also uncovered further information about the nature of the
HI state of host-passaged V. cholerae. We found that passive
transit through the intestinal lumen of naive mice does not
confer hyperinfectivity, but instead, SI colonization is required.
This suggests that the SI lumen and epithelium represent distinct
environments with respect to the signals needed for inducing
hyperinfectivity. Consistent with this, we found that full induction
of tcpA expression only occurs within the colonized population, as
previously observed [6], whereas passive transit through the SI
failed to fully induce this gene. Whether other genes induced
during infection also require colonization, rather than transient
passage, for their induction remains to be determined.
We observed that a fraction of a high-dose V. cholerae in-
oculum can overcome the vaccine protection and is retained in
the SI for up to 24 hours. However, these bacteria fail to fully
induce tcpA, suggesting that they are in a microenvironment
that is different from that of bacteria that colonize a naive host.
It may be that these bacteria colonize the mucus layer in the SI of
immune mice but fail to penetrate further to the SI epithelium,
perhaps being held up by antibody binding.
In summary, we have shown that OMV immunization can
reduce SI colonization in a passive-protection model even when
the challenge bacteria are in the natural rice-water-stool HI state.
We show that V. cholerae exiting an immune host, having failed
to colonize, occurs on large clumps and is hypoinfectious. And,
finally, we show that colonization is required for full virulence
gene expression and to induce the HI state.
Supplementary Data
Supplementary materials are available at The Journal of Infectious Diseases
online (http://www.oxfordjournals.org/our_journals/jid/). Supplementary
materials consist of data provided by the author that are published to benefit
the reader. The posted materials are not copyedited. The contents of all
Figure 6. Expression of tcpA by Vibrio cholerae upon passage through immunized or unimmunized mice monitored using resolution. Resolution under
the control of the tcpA promoter was monitored through the proportion of resolved, tetracycline-sensitive (TcS) V. cholerae AC585. Percentage of tcpA
resolution 5 [(Total CFU – TcR CFU)/Total CFU) 3 100/% resolution of the input]. A, tcpA expression in control conditions of Luria-Bertani (LB)–grown
(noninducing condition) or what is known as ''AKI'' culture (inducing condition). Each symbol represents 1 culture. B, tcpA expression 24 hours
postinoculation in V. cholerae from homogenates of small intestine (SI) or large intestine (LI) from neonates born to unimmunized mice infected with
105 CFU or outer-membrane vesicle (OMV)–immunized mice challenged with 107 colony-forming units (CFU). C, tcpA expression 2 hours postinoculation in
SI and LI upon infection of neonates born to unimmunized or OMV-immunized (OMV) mice with a V. cholerae challenge dose of 107 CFU. Each symbol
represents the percentage of resolution for1 infected neonate; bars 5 medians. *P , .05 (Mann–Whitney U test). Where pups suckled by OMV-
immunized mice were infected, anti-OMV immunoglobulin (Ig) G1 antibody titers (terminal bleeds) for the dams were between 23.4 and 25.7 (median,
25.3) lg/mL. D, Total tissue viable counts for V. cholerae infections for which resolution data are shown in (B ) and (C ). The input doses are indicated.
Each symbol represents viable counts for the SI or LI from 1 infected unimmunized or OMV-immunized neonate either 2 hours or 24 hours postinoculation,
as indicated. Bars 5 medians.
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supplementary data are the sole responsibility of the authors. Questions or
messages regarding errors should be addressed to the author.
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